Xarelto

Anticoagulant Linked to Stroke, Blood Clots, Internal Bleeding

Xarelto LawsuitsXarelto is one of several drugs in a new class of anticoagulants (blood thinners) called direct factor Xa inhibitors. The first of these new class of drugs to gain FDA approval was Pradaxa. The man- ufacturer of Pradaxa®, Boehringer Ingelheim, settled the lawsuits it was facing, agreeing to pay $650 million to approximately 4,000 people across the United Sates for similar bleeding injuries.

Xarelto, like other blood thinners, carries a risk of internal bleeding. However, there is evidence showing that Xarelto is not as safe or effective as other blood thinners and that the internal bleeding caused by Xarelto cannot be controlled or reversed by physicians, unlike the traditional class of blood thinners which includes Coumadin (warfarin). The Institute for Safe Medication Practices (ISMP) advises that Xarelto has been associated with “serious, disabling or fatal injury,” including blood clots or thromboembolic events.

AWKO Senior Partner Appointed to Xarelto Steering Committee

The attorneys of Aysltock, Witkin, Kreis & Overholtz have been at the forefront of the fight for justice for patients injured as a result of ingesting Xarelto. Senior partner Neil Overholtz was appointed by the federal judge overseeing all cases nationwide to the Plaintiff’s Steering Committee.

AWKO attorneys have been involved in every Xarelto trial in the country and have led the charge in assembling the evidence necessary to show that the manufacturer failed to adequately warn consumers and their doctors about the risks associated with Xarelto.

Have You Been Injured By Xarelto?

If you or a loved one suffered a harmful side effect such as a stroke, blood clot, or internal bleeding while taking Xarelto, you may have a valuable legal claim. Contact us today at (844) 794-7402 to speak with one of the attorneys on the forefront of the Xarelto® litigation.

Bibliography and References

Bibliography
If additional resources are available, they will be linked here.
Additional Resources
If additional resources are available, they will be linked here.